Pain Treatment Department, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, 300060 Tianjin, China.
Nursing Department, Shanghai Gonghui Hospital, 200050 Shanghai, China.
Arch Esp Urol. 2024 Jul;77(6):695-702. doi: 10.56434/j.arch.esp.urol.20247706.95.
Patients with advanced prostate cancer commonly experience psychological issues and have a low quality of life. This study aims to analyse the application of supportive psychotherapy combined with analgesic management on the pain and quality of life of patients with advanced prostate cancer.
Patients with advanced prostate cancer admitted to our hospital from February 2018 to December 2022 were continuously selected as the research objects. In accordance with the different management methods recorded in the medical record system, the patients were divided into a control group (routine nursing + analgesic management) and an observation group (routine nursing + analgesic management + supportive psychotherapy). The Athens Insomnia Scale (AIS), State Anxiety Scale (S-AI), Trait Anxiety Scale (T-AI), Numeric Rating Scale (NRS) and 36-Item Short-Form Health Survey (SF-36) scores between the two groups were compared.
A total of 125 patients with advanced prostate cancer participated in this study, with 60 patients in the control group and 65 patients in the observation group. No significant difference was found in the scores of the AIS, S-AI, T-AI, NRS and SF-36 of the two groups before management ( > 0.05). After management, the AIS (4.00 vs. 5.00, = 0.002), S-AI (38.88 vs. 41.12, = 0.002), T-AI (39.17 vs. 41.65, = 0.001) and NRS (3.00 vs. 3.00, < 0.001) scores of the observation group were lower than those of the control group. However, the SF-36 scores of the observation group were higher than those of the control group in the dimensions of physiological enginery (75.85 vs. 68.75, < 0.001), physiological function (71.85 vs. 67.75, = 0.004), body pain (73.15 vs. 69.33, = 0.006), social function (73.88 vs. 69.85, = 0.004), emotional function (72.92 vs. 68.98, = 0.006), mental health (73.52 vs. 69.83, = 0.008), vitality (72.09 vs. 69.52, = 0.044) and general health (70.65 vs. 66.23, = 0.002).
Supportive psychotherapy combined with analgesic management for patients with advanced prostate cancer may help improve the pain, anxiety and quality of sleep and life of patients.
晚期前列腺癌患者常伴有心理问题，生活质量较低。本研究旨在分析支持性心理治疗联合镇痛管理对晚期前列腺癌患者疼痛和生活质量的影响。
连续选取 2018 年 2 月至 2022 年 12 月我院收治的晚期前列腺癌患者作为研究对象。根据病历系统记录的不同管理方法，将患者分为对照组（常规护理+镇痛管理）和观察组（常规护理+镇痛管理+支持性心理治疗）。比较两组患者的雅典失眠量表（AIS）、状态焦虑量表（S-AI）、特质焦虑量表（T-AI）、数字评分量表（NRS）和 36 项简明健康状况量表（SF-36）评分。
共有 125 例晚期前列腺癌患者参与本研究，其中对照组 60 例，观察组 65 例。两组患者管理前 AIS、S-AI、T-AI、NRS 和 SF-36 评分比较，差异均无统计学意义（均>0.05）。管理后，观察组 AIS（4.00 分比 5.00 分，=0.002）、S-AI（38.88 分比 41.12 分，=0.002）、T-AI（39.17 分比 41.65 分，=0.001）和 NRS（3.00 分比 3.00 分，<0.001）评分均低于对照组，而观察组 SF-36 评分在生理机能（75.85 分比 68.75 分，<0.001）、生理功能（71.85 分比 67.75 分，=0.004）、躯体疼痛（73.15 分比 69.33 分，=0.006）、社会功能（73.88 分比 69.85 分，=0.004）、情感功能（72.92 分比 68.98 分，=0.006）、心理健康（73.52 分比 69.83 分，=0.008）、活力（72.09 分比 69.52 分，=0.044）和总体健康（70.65 分比 66.23 分，=0.002）等维度评分均高于对照组。
支持性心理治疗联合镇痛管理可改善晚期前列腺癌患者的疼痛、焦虑和睡眠质量，提高其生活质量。
